Paper Review Records
All Paper Review Records
6 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
71
days
Will They Use It? Patient and Provider Acceptance of Chatbot Screening and Counseling for Hereditary Cancer Syndromes in a Geographically Underserved Population
Authors
Madison R. Coleman; Kaylee A. Underkofler; Martha H. Thomas; Alisha Gupta; Alayna A. Panzer; Kara S. Fitzgibbon; Kari L. RingShow moreShow less
Affiliations
1. University of Virginia Health System 1 Department of Obstetrics and Gynecology, , Charlottesville, Virginia.; 2. University of Virginia Health System 2 Emily Couric Clinical Cancer Center, , Charlottesville, Virginia.; 3. Randolph-Macon College 3 Department of Economics, Business, and Accounting, , Ashland, Virginia.; 4. University of Virginia 4 Center for Survey Research, , Charlottesville, Virginia.Show moreShow less
121
days
Precision Cancer Prevention Needs Both Implementation Science and Ethics
Authors
Alexandra Wicker; Amanda Courtright-Lim; Lila J. Finney Rutten; Steven W. Ressler; Jon C. Tilburt; Jessica D. AustinShow moreShow less
Affiliations
1. Mayo Clinic 1 Department of Quantitative Health Sciences, , Phoenix, Arizona.; 2. Mayo Clinic 2 Division of Epidemiology, , Rochester, Minnesota.; 3. Mayo Clinic 3 Department of Quantitative Health Science, , Rochester, Minnesota.; 4. Mayo Clinic 4 Department of Internal Medicine, , Phoenix, Arizona.; 5. 5Stephenson Cancer Center, University of Oklahoma, Oklahoma City, Oklahoma.Show moreShow less
138
days
The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial
Authors
Leigha Senter; Shelly Hovick; Rachel Notestine; Lauren Norden; Nadia Benny; Shannon Phillips; Ava Willoughby; Robert Pyatt; Doreen Agnese; Julie S. Mak; Allison DePersia; Sarah V. Colonna; Whitney F. Maxwell; Wendy Kohlmann; Erika L. Spaeth; Ora Gordon; Darcy Thull; Guy N. Brock; Amy Webb; Rachel M. Smith; Amanda Ewart TolandShow moreShow less
Affiliations
1. 1Division of Human Genetics, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.; 2. The Ohio State University 2 School of Communication, , Columbus, Ohio.; 3. 3Division of Human Genetics, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio.; 4. 4Department of Cancer Biology and Genetics, The Ohio State University Wexner Medical Center, Columbus, Ohio.; 5. Nationwide Children’s Hospital 5 The Steve and Cindy Rasmussen Institute for Genomic Medicine, , Columbus, Ohio.; 6. Nationwide Children’s Hospital 6 Department of Pathology and Laboratory Medicine, , Columbus, Ohio.; 7. 7Department of Pathology, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio.; 8. 8Division of Surgical Oncology, The Ohio State University Wexner Medical Center, Columbus, Ohio.; 9. University of California San Francisco Helen Diller Family Comprehensive Cancer Center 9 , San Francisco, California.; 10. NorthShore University HealthSystem 10 Neaman Center for Personalized Medicine Endeavor Health, , Evanston, Illinois.; 11. 11Department of Internal Medicine, University of Utah, USA, Salt Lake City, Utah.; 12. Huntsman Cancer Institute 12 , University of Utah, USA, Salt Lake City, Utah.; 13. 13Genetic Technologies Ltd, Charlotte, North Carolina.; 14. 14Rhythm Biosciences Ltd, Charlotte, North Carolina.; 15. 15Providence Saint John's Cancer Institute, Santa Monica, California.; 16. 16Department of Hematology/Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; 17. 17UPMC Magee Center for Medical Genetics and Genomics, Pittsburgh, Pennsylvania.; 18. The Ohio State University 18 Center for Biostatistics, College of Medicine, , Columbus, Ohio.; 19. The Ohio State University 19 Department of Biomedical Informatics, , Columbus, Ohio.Show moreShow less
89
days
Early Detection of Cancer in Medically Underserved Populations
Authors
Ernest T. Hawk; Stephanie L. MartchShow moreShow less
Affiliations
1. The University of Texas MD Anderson Cancer Center Division of Cancer Prevention and Population Sciences, , Houston, Texas.Show moreShow less
103
days
TP53-Mutated Preneoplastic Colonies, Adaptive Immune Response, and Risk for Lung Cancer and COPD
Authors
James C. Willey; Andrew R. Boring; Erin L. Crawford; Kevin N. Lei; Thomas M. Blomquist; Christopher I. Amos; Stephen A. Deppen; Eric L. Grogan; Heidi Chen; Mohamed Omballi; Daniel J. CraigShow moreShow less
Affiliations
1. The University of Toledo College of Medicine, Toledo, Ohio.; 2. University of New Mexico , Albuquerque, New Mexico.; 3. Vanderbilt University Medical Center , Nashville, Tennessee.; 4. Promedica , Toledo, Ohio.Show moreShow less
8
days
Advancing Gastric Cancer Chemoprevention: Early Signals and Ongoing Challenges
Authors
Jimyung Park; Ryan H. MoyShow moreShow less
Affiliations
1. Columbia University Irving Medical Center 1 Division of Hematology/Oncology, Department of Medicine, , New York, New York.Show moreShow less
FAQ
How long does Cancer Prevention Research take to review a manuscript?
As of 2026-11-19, CrushSCI has 6 complete review records for Cancer Prevention Research. The fastest paper went from submission to acceptance in 8 days (Advancing Gastric Cancer Chemoprevention: Early Signals and Ongoing Challenges, received 2026-04-23, accepted 2026-05-01); the slowest took 138 days. The average is 88.3 days and the median is 96 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
